Filtros de búsqueda

Lista de obras de

A first-in-human phase I trial of LY2780301, a dual p70 S6 kinase and Akt Inhibitor, in patients with advanced or metastatic cancer

artículo científico publicado en 2015

Capturing Hyperprogressive Disease with Immune-Checkpoint Inhibitors Using RECIST 1.1 Criteria

scientific article published on 22 November 2019

Clinical development of phosphatidylinositol 3-kinase inhibitors for cancer treatment

artículo científico publicado en 2012

Evolution of clinical trial design in early drug development: systematic review of expansion cohort use in single-agent phase I cancer trials

artículo científico

First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours

artículo científico publicado en 2020

First-in-human dose study of the novel transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate in patients with advanced cancer and glioma

artículo científico publicado en 2014

Locally advanced head and neck squamous cell cancer: treatment choice based on risk factors and optimizing drug prescription ⬇️

artículo científico publicado el 1 de septiembre de 2012

Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer

artículo científico publicado en 2014

The Personalization of Therapy: Molecular Profiling Technologies and Their Application

artículo científico publicado en 2015

Toxicity as a Biomarker of Efficacy of Molecular Targeted Therapies: Focus on EGFR and VEGF Inhibiting Anticancer Drugs ⬇️

artículo científico publicado el 1 de enero de 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda